Trends in cancer mortality in Spain: the influence of the financial crisis
Por:
Ferrando, J, Palencia, L, Gotsens, M, Puig-Barrachina, V, Mari-Dell'Olmo, M, Rodriguez-Sanz, M, Bartoll, X, Borrell, C
Publicada:
1 may 2019
Resumen:
Objective: To determine if the onset of the economic crisis in Spain affected cancer mortality and mortality trends.
Method: We conducted a longitudinal ecological study based on all cancer-related deaths and on specific types of cancer (lung, colon, breast and prostate) in Spain between 2000 and 2013. We computed age standardised mortality rates in men and women, and fit mixed Poisson models to analyse the effect of the crisis on cancer mortality and trends therein.
Results: After the onset of the economic crisis, cancer mortality continued to decline, but with a significant slowing of the yearly rate of decline (men: RR = 0.987, 95%Cl= 0.985-0.990, before the crisis, and RR = 0.993, 95%Cl = 0.991-0.996, afterwards; women: RR = 0.990, 95%Cl = 0.988-0.993, before, and RR = 1.002, 95%Cl = 0.998-1.006, afterwards). In men, lung cancer mortality was reduced, continuing the trend observed in the pre-crisis period; the trend in colon cancer mortality did not change significantly and continued to increase; and the yearly decline in prostate cancer mortality slowed significantly. In women, lung cancer mortality continued to increase each year, as before the crisis; colon cancer continued to decease; and the previous yearly downward trend in breast cancer mortality slowed down following the onset of the crisis.
Conclusions: Since the onset of the economic crisis in Spain the rate of decline in cancer mortality has slowed significantly, and this situation could be exacerbated by the current austerity measures in healthcare. (C) 2018 SESPAS. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Filiaciones:
Ferrando, J:
Agencia Salut Publ Barcelona, Barcelona, Spain
Palencia, L:
Agencia Salut Publ Barcelona, Barcelona, Spain
CIBERESP, Madrid, Spain
Inst Invest Biomed IIB St Pau, Barcelona, Spain
Gotsens, M:
Agencia Salut Publ Barcelona, Barcelona, Spain
CIBERESP, Madrid, Spain
Inst Invest Biomed IIB St Pau, Barcelona, Spain
Puig-Barrachina, V:
Agencia Salut Publ Barcelona, Barcelona, Spain
Mari-Dell'Olmo, M:
Agencia Salut Publ Barcelona, Barcelona, Spain
CIBERESP, Madrid, Spain
Inst Invest Biomed IIB St Pau, Barcelona, Spain
Rodriguez-Sanz, M:
Agencia Salut Publ Barcelona, Barcelona, Spain
CIBERESP, Madrid, Spain
Inst Invest Biomed IIB St Pau, Barcelona, Spain
Univ Pompeu Fabra, Fac Ciencias Salud & Vida, Dept Ciencias Expt & Salud, Barcelona, Spain
Bartoll, X:
Agencia Salut Publ Barcelona, Barcelona, Spain
Inst Invest Biomed IIB St Pau, Barcelona, Spain
Borrell, C:
Agencia Salut Publ Barcelona, Barcelona, Spain
CIBERESP, Madrid, Spain
Inst Invest Biomed IIB St Pau, Barcelona, Spain
Univ Pompeu Fabra, Fac Ciencias Salud & Vida, Dept Ciencias Expt & Salud, Barcelona, Spain
Gold
|